FY2025 · ended Dec 31, 2025 · Revenue $6.55B, -3.4% YoY · Filed Feb 11, 2026
Avantor, Inc. (AVTR) files with the SEC under industry code 3826, Laboratory Analytical Instruments. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $6.6 billion and a net loss of $530.2 million. Free cash flow was $495.0 million. As of Sep 30, 2026 it held $464.3 million in cash and investments and $3.7 billion in total debt.
Revenue (TTM)
$6.64B
+0.9% vs year-ago TTM
Net income (TTM)
$337.20M
+510.2% vs year-ago TTM
Operating cash flow (TTM)
$584.70M
-9.3% vs year-ago TTM
Free cash flow (TTM)
$439.20M
-16.1% vs year-ago TTM
EPS (TTM)
$0.50
+512.4% vs year-ago TTM
Dividend per share
None
Shares outstanding
682.06M
+0.2% vs prior year
Net cash
$-3.22B
as of Sep 30, 2026
Operating margin
7.3%
FY 2026
Company profile
- Industry
- Laboratory Analytical Instruments (SIC 3826)
- Listed as
- AVTR (NYSE)
- Fiscal year ends
- December 31
- Headquarters
- Radnor, PA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1722482
- Former names
- Vail Holdco Corp (until Dec 28, 2017)
Other Laboratory Analytical Instruments companies
- Agilent Technologies, Inc. A
- Waters Corp /DE/ WAT
- Illumina, Inc. ILMN
- Mettler Toledo International INC/ MTD
- Revvity, Inc. RVTY
- Bio-Rad Laboratories, Inc. BIO
- Bruker Corp BRKR
- 10x Genomics, Inc. TXG
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2020 Dec 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $6.6B | $6.8B | $7.0B | $7.5B | $7.4B |
| Operating income | -$246.2M | $1.1B | $696.4M | $1.1B | $972.2M |
| Net income | -$530.2M | $711.5M | $321.1M | $686.5M | $572.6M |
| Diluted EPS | -$0.78 | $1.04 | $0.47 | $1.01 | $0.85 |
| Operating cash flow | $623.8M | $840.8M | $870.0M | $843.6M | $953.6M |
| Free cash flow | $495.0M | $692.0M | $723.6M | $710.2M | $842.5M |
| Total assets | $11.8B | $12.1B | $13.0B | $13.5B | $13.9B |
| Total liabilities | $6.2B | $6.2B | $7.7B | $8.6B | $9.7B |
| Stockholders' equity | $5.6B | $6.0B | $5.3B | $4.9B | $4.2B |
| Cash and investments | $365.4M | $261.9M | $262.9M | $372.9M | $301.7M |
| Total debt | $4.2B | $4.2B | $5.7B | $6.5B | $7.2B |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Officer or director change
|
Nov 3, 2026 | Oct 30, 2026 |
| 10-Q | Quarterly report | Oct 28, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Oct 28, 2026 | Oct 28, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Sep 21, 2026 | Sep 17, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Sep 21, 2026 | Sep 17, 2026 |
| 8-K/A |
Amended current report
Officer or director change
|
Aug 27, 2026 | Apr 17, 2026 |
All 787 Avantor, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.